<?xml version="1.0" encoding="UTF-8"?>
<p id="Par94">In COVID-19 patients heart failure is a major concern. Patients with pre-existing cardiovascular disease are more likely to be infected with SARS-CoV-2 and are more likely to develop severe symptoms. There are several potential mechanisms. Myocarditis can result directly from local infection with SARS-CoV-2 and the local immune response [
 <xref ref-type="bibr" rid="CR165">165</xref>]. ACE2 receptor disruption may cause damage by preventing conversion of AII to Ang (1â€“7) [
 <xref ref-type="bibr" rid="CR7">7</xref>]. Toxic effects of endogenous or exogenous catecholamines may evoke a takotsubo cardiopathy pattern [
 <xref ref-type="bibr" rid="CR67">67</xref>, 
 <xref ref-type="bibr" rid="CR120">120</xref>, 
 <xref ref-type="bibr" rid="CR123">123</xref>, 
 <xref ref-type="bibr" rid="CR136">136</xref>, 
 <xref ref-type="bibr" rid="CR148">148</xref>]. There may be endothelial or microvascular dysfunction or instability of coronary arterial plaque [
 <xref ref-type="bibr" rid="CR80">80</xref>].
</p>
